Skip to main content
. 2018 Apr 13;9(28):19555–19568. doi: 10.18632/oncotarget.24656

Table 3. Literature review of TP53 variant and prognostic analysis in DLBCL.

TP53 mutation 17p deletion/TP53 loss Mutation with17p deletion/TP53 loss
Treatment Study Year Total cases OS PFS/DFS OS PFS/DFS OS PFS/DFS
CHOP era Ichikawa A et al. 1997 [23] 102 poor
Stokke T et al. 2001 [24] 94 poor
Leroy K et al. 2002 [25] 69 poor
Young KH et al. 2007 [26] 113 poor NS NS
Stöcklein H et al. 2008 [27] 40 NS NS poor
Young KH et al. 2008 [28] 477 poor
R-CHOP era Xu-Monette ZY et al. 2012 [29] 506 poor poor NS NS
Asmar F et al. 2014 [30] 62 poor
Fiskvik I et al. 2015 [31] 43 poor poor
Cao Y et al. 2016 [14] 165 poor poor poor poor
Zenz T et al. 2017 [32] 265 poor poor
Present study 2017 120 35 (Discovery cohort) NS* NS* NS# NS# poor poor
85 (Validation cohort) NS* NS* NS# NS# poor poor

NS: not significant, *: TP53 mutation only, #: 17p deletion/TP53 loss only.